Position in MLYS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$213,245,549
-$869,422 QoQ
Shares Held
7,903,838
0.0% QoQ
Ownership
8.94%
of shares outstanding
% of Portfolio
92.94%
of 13F equity value
Holder Rank
#1
of 224 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Catalys Pacific, LLC holds $229,453,864 across 2 Biotechnology names. MLYS ranks #1 (92.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
This page
|
7,903,838 | $213,245,549 | |
| 2 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,493,854 | $16,208,315 |
All Filings in MLYS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $213,245,549 | 7,903,838 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $214,114,971 | 7,903,838 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $286,830,281 | 7,903,838 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $337,633,536 | 8,903,838 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $120,468,928 | 8,903,838 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $141,392,947 | 8,903,838 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $106,414,767 | 8,644,579 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $104,685,851 | 8,644,579 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $107,576,574 | 9,194,579 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $118,702,014 | 9,194,579 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $79,073,379 | 9,194,579 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||